Search
forResearch 10 of 1000+
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- NF-κB in biology and targeted therapy: new insights and translational implications
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Role of Silver Nanoparticles in Wound Healing: Mechanisms, Efficacy, and Clinical Applications
- PROTACs: A novel strategy for cancer drug discovery and development
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Contents
- Evidence of a Causal Relationship Between Body Mass Index and Immune-Mediated and Inflammatory Skin Diseases and Biomarkers: A Mendelian Randomization Study
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →